Emergent Biosolutions EBS Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's operating lease right-of-use assets in other assets?
- Emergent Biosolutions (EBS) reported operating lease right-of-use assets in other assets of $9.9M in Q1 2026.
- How has Emergent Biosolutions's operating lease right-of-use assets in other assets changed year-over-year?
- Emergent Biosolutions's operating lease right-of-use assets in other assets increased by 50.0% year-over-year, from $6.6M to $9.9M.
- What is the long-term trend for Emergent Biosolutions's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Emergent Biosolutions's operating lease right-of-use assets in other assets has grown at a -19.3% compound annual growth rate (CAGR), from $31M to $10.6M.